Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Interferon-alpha × Clear all

NCT00095862 2018-02-05

Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

Phase 1/2 Terminated

Breast Neoplasms, Breast Neoplasms, Male